Molina Healthcare (NYSE:MOH) was upgraded by research analysts at JPMorgan Chase & Co. from a “neutral” rating to an “overweight” rating in a report issued on Tuesday, MarketBeat reports.

MOH has been the subject of a number of other research reports. ValuEngine raised shares of Molina Healthcare from a “hold” rating to a “buy” rating in a research report on Thursday, November 9th. BMO Capital Markets began coverage on shares of Molina Healthcare in a report on Monday, October 16th. They issued a “market perform” rating and a $70.00 price target for the company. Mitsubishi UFJ Financial Group began coverage on shares of Molina Healthcare in a report on Thursday, September 21st. They issued a “neutral” rating and a $70.00 price target for the company. Raymond James Financial reaffirmed a “hold” rating on shares of Molina Healthcare in a report on Friday, December 8th. Finally, Leerink Swann raised their price target on shares of Molina Healthcare from $100.00 to $105.00 and gave the stock an “outperform” rating in a report on Tuesday, January 9th. Three research analysts have rated the stock with a sell rating, ten have given a hold rating, four have given a buy rating and one has issued a strong buy rating to the stock. Molina Healthcare presently has an average rating of “Hold” and an average price target of $70.86.

Molina Healthcare (NYSE MOH) traded up $1.80 during trading hours on Tuesday, reaching $93.77. 1,637,817 shares of the company were exchanged, compared to its average volume of 1,464,901. Molina Healthcare has a 12 month low of $42.56 and a 12 month high of $93.85. The company has a debt-to-equity ratio of 1.06, a current ratio of 1.29 and a quick ratio of 1.29. The stock has a market capitalization of $5,290.00, a PE ratio of -17.79, a price-to-earnings-growth ratio of 1.15 and a beta of 0.97.

Molina Healthcare (NYSE:MOH) last posted its earnings results on Thursday, November 2nd. The company reported ($1.62) EPS for the quarter, missing the Zacks’ consensus estimate of $0.23 by ($1.85). Molina Healthcare had a negative net margin of 1.76% and a positive return on equity of 17.76%. The firm had revenue of $5.03 billion for the quarter, compared to analysts’ expectations of $4.95 billion. During the same period in the previous year, the company earned $0.85 EPS. The company’s revenue was up 10.7% on a year-over-year basis. equities analysts anticipate that Molina Healthcare will post -3.88 earnings per share for the current fiscal year.

In other news, insider William Dentino sold 67,500 shares of the business’s stock in a transaction that occurred on Wednesday, November 15th. The shares were sold at an average price of $77.15, for a total value of $5,207,625.00. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, COO Terry Bayer sold 9,077 shares of the business’s stock in a transaction that occurred on Monday, November 6th. The shares were sold at an average price of $77.45, for a total transaction of $703,013.65. Following the completion of the sale, the chief operating officer now directly owns 74,478 shares in the company, valued at $5,768,321.10. The disclosure for this sale can be found here. Insiders sold a total of 700,452 shares of company stock worth $53,463,251 over the last three months. Insiders own 6.20% of the company’s stock.

Several hedge funds have recently made changes to their positions in the stock. Commonwealth of Pennsylvania Public School Empls Retrmt SYS grew its holdings in shares of Molina Healthcare by 0.4% in the second quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 6,240 shares of the company’s stock valued at $432,000 after purchasing an additional 23 shares in the last quarter. Amalgamated Bank grew its holdings in shares of Molina Healthcare by 4.3% in the second quarter. Amalgamated Bank now owns 6,237 shares of the company’s stock valued at $431,000 after purchasing an additional 258 shares in the last quarter. Mutual of America Capital Management LLC grew its holdings in shares of Molina Healthcare by 0.9% in the second quarter. Mutual of America Capital Management LLC now owns 35,140 shares of the company’s stock valued at $2,431,000 after purchasing an additional 325 shares in the last quarter. Ameritas Investment Partners Inc. grew its holdings in shares of Molina Healthcare by 2.2% in the second quarter. Ameritas Investment Partners Inc. now owns 16,659 shares of the company’s stock valued at $1,152,000 after purchasing an additional 364 shares in the last quarter. Finally, Thrivent Financial For Lutherans grew its holdings in shares of Molina Healthcare by 6.3% in the second quarter. Thrivent Financial For Lutherans now owns 8,580 shares of the company’s stock valued at $594,000 after purchasing an additional 510 shares in the last quarter.

COPYRIGHT VIOLATION NOTICE: “Molina Healthcare (MOH) Upgraded at JPMorgan Chase & Co.” was first reported by Daily Political and is the property of of Daily Political. If you are accessing this piece of content on another domain, it was stolen and republished in violation of international copyright & trademark legislation. The original version of this piece of content can be accessed at https://www.dailypolitical.com/2018/01/18/molina-healthcare-moh-upgraded-at-jpmorgan-chase-co.html.

Molina Healthcare Company Profile

Molina Healthcare, Inc offers Medicaid-related solutions for low-income families and individuals, and assists government agencies in their administration of the Medicaid program. The Company operates through three segments: Health Plans, Molina Medicaid Solutions and Other, which includes its Pathways Health and Community Support LLC (Pathways) business.

Analyst Recommendations for Molina Healthcare (NYSE:MOH)

Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.